A prospective audit on the use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline-cyclophosphamide.
暂无分享,去创建一个
R. Isaacs | G. Forgeson | L. Satterthwaite | Navin T Wewala | Edward Lo | M. Anderson | Rebecca Carroll | Jody Jordan | Jennifer Fernando | Malcolm C. Anderson